Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways

Bibliographic Details
Main Authors: Jie Wang, Pingping Shi, Huaixiang Teng, Lixiang Lu, Hailong Guo, Xiuqin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.819908/full
_version_ 1818314967221272576
author Jie Wang
Pingping Shi
Huaixiang Teng
Lixiang Lu
Hailong Guo
Xiuqin Wang
author_facet Jie Wang
Pingping Shi
Huaixiang Teng
Lixiang Lu
Hailong Guo
Xiuqin Wang
author_sort Jie Wang
collection DOAJ
first_indexed 2024-12-13T08:58:03Z
format Article
id doaj.art-bd3534fc8db34a3ba30a56b673c17e47
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-13T08:58:03Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-bd3534fc8db34a3ba30a56b673c17e472022-12-21T23:53:15ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-03-011210.3389/fonc.2022.819908819908Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 PathwaysJie Wang0Pingping Shi1Huaixiang Teng2Lixiang Lu3Hailong Guo4Xiuqin Wang5Gynaecology Clinic, People’s Hospital of Rizhao, Rizhao, ChinaNo. 2 Department of Gynaecology, People’s Hospital of Rizhao, Rizhao, ChinaReproductive Medicine Center, Maternal and Child Health Hospital of Rizhao, Rizhao, ChinaNo. 2 Department of Gynaecology, Baiqiuen Hospital of Rizhao, Rizhao, ChinaNo. 2 Department of Gynaecology, People’s Hospital of Rizhao, Rizhao, ChinaNo. 2 Department of Gynaecology, People’s Hospital of Rizhao, Rizhao, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2022.819908/fullendometrial cancerlong noncoding RNADC-STAMP domain-containing 1-antisense 1microRNA-665homeobox B5microRNA-873-5p
spellingShingle Jie Wang
Pingping Shi
Huaixiang Teng
Lixiang Lu
Hailong Guo
Xiuqin Wang
Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
Frontiers in Oncology
endometrial cancer
long noncoding RNA
DC-STAMP domain-containing 1-antisense 1
microRNA-665
homeobox B5
microRNA-873-5p
title Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_full Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_fullStr Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_full_unstemmed Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_short Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_sort corrigendum lncrna dcst1 as1 promotes endometrial cancer progression by modulating the mir 665 hoxb5 and mir 873 5p cadm1 pathways
topic endometrial cancer
long noncoding RNA
DC-STAMP domain-containing 1-antisense 1
microRNA-665
homeobox B5
microRNA-873-5p
url https://www.frontiersin.org/articles/10.3389/fonc.2022.819908/full
work_keys_str_mv AT jiewang corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT pingpingshi corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT huaixiangteng corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT lixianglu corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT hailongguo corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT xiuqinwang corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways